The University of Chicago Header Logo

A phase I study of continuous infusion cilengitide in patients with solid tumors.

A phase I study of continuous infusion cilengitide in patients with solid tumors. Invest New Drugs. 2012 Apr; 30(2):604-10.

View in: PubMed